SILVER SPRING, Md., April 26, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into a binding letter of commitment (the "Agreement") with Dayton Professional Baseball, LLC ("DPB"), the owner of the Dayton Dragons professional baseball team. The Agreement is part of a new marketing initiative to launch Clotamin in 90 stores owned and operated by a national retail chain in the Cincinnati-Dayton District.
Under terms of the Agreement, in conjunction with the retailer, DPB will create and run a Corporate Marketing Program centered on Clotamin in stores. As with previous in-store agreements, the Company anticipates that counter point-of-sale (POS) displays featuring Clotamin will be prominently placed in each retail location for the duration of the program – approximately seven months, beginning on April 30, 2012.
During the consumer marketing and advertising program, Clotamin is also expected to be featured at the Dayton Dragons home games on signage and other marketing elements throughout the Fifth Third Field in Dayton, Ohio. The Dayton Dragons are the first (and only) team in minor league baseball history to sell out an entire season before it began and was voted as one of the Top Ten Hottest Tickets to get in all of professional sports by Sports Illustrated. The Dayton Dragons' series of 815 consecutive sellouts surpassed the longest sellout streak across all professional sports in the U.S.
"We are excited to be associating Clotamin with one of the most popular teams in all of pro sports. Their incredible attendance record is testament to the quality of the game on field, loyal fans, and marketing know-how," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "Once again, the marketing combination of a national retailer with a highly-recognizable pro sports team is designed to allow us to quickly introduce Clotamin into a geographic area. We look forward to working closely with the team to make this a successful Clotamin launch."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or [email protected]
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.